About Thera Tears
Thera Tears was founded in 1997 by Jeffrey Gilbard in Ann Arbor, United States. Operations are focused on the ophthalmic products sector, where eye drops are produced for dry eye relief and related conditions. Manufacturing processes are conducted domestically, with distribution handled through healthcare channels. The company maintains a presence in the eye care industry, serving consumers and professionals across the United States.
- Headquarter Ann Arbor, United States
- Founders Jeffrey Gilbard
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Prestige Consumer Healthcare Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Prestige Brands
& 1 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Thera Tears
Detailed funding history for Thera Tears
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Thera Tears
Thera Tears has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Prestige Brands and Akorn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Over-the-counter healthcare products are provided for consumer health needs.
|
Locked | Locked | Locked | |
|
Injectable and ophthalmic pharmaceutical products were manufactured across therapeutic areas.
|
Locked | Locked | Locked |
Investor details for Thera Tears
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Thera Tears
Investment portfolio details for Thera Tears
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Thera Tears
Detailed financials for Thera Tears
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Thera Tears Comparisons
Peer comparison for Thera Tears
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Thera Tears
Detailed competitors of Thera Tears
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Thera Tears
Complete news archive for Thera Tears
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thera Tears
Thera Tears was founded in 1997.
Thera Tears is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Thera Tears was founded in 1997 by Jeffrey Gilbard in Ann Arbor, United States. Operations are focused on the ophthalmic products sector, where eye drops are produced for dry eye relief and related conditions. Manufacturing processes are conducted domestically, with distribution handled through healthcare channels. The company maintains a presence in the eye care industry, serving consumers and professionals across the United States.
Thera Tears has 2 investors. Key investors include Prestige Brands, and Akorn.